UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 460

Sortiert nach

HIV infection: epidemiology, pathogenesis, treatment, and prevention

The Lancet (British edition), 2014-07, Vol.384 (9939), p.258-271

2014

Link zum Volltext

Verfügbarkeit prüfen

‘Covering the tail’ after stopping efavirenz-based antiretroviral therapy

Southern African journal of HIV medicine, 2020, Vol.21 (1), p.1-2

Maartens, Gary

2020

Link zum Volltext

Verfügbarkeit prüfen

Systematic review of antiretroviral-associated lipodystrophy: lipoatrophy, but not central fat gain, is an antiretroviral adverse drug reaction

PloS one, 2013-05, Vol.8 (5), p.e63623

2013

Link zum Volltext

Verfügbarkeit prüfen

Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome

AIDS (London), 2010-09, Vol.24 (15), p.2381-2390

2010

Link zum Volltext

Verfügbarkeit prüfen

Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial

The Lancet (British edition), 2014-08, Vol.384 (9944), p.682-690

2014

Link zum Volltext

Verfügbarkeit prüfen

Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings

The Lancet infectious diseases, 2008-08, Vol.8 (8), p.516-523

2008

Link zum Volltext

Verfügbarkeit prüfen

Safety and adherence to intermittent pre-exposure prophylaxis (PrEP) for HIV-1 in African men who have sex with men and female sex workers

PloS one, 2012-04, Vol.7 (4), p.e33103

2012

Link zum Volltext

Verfügbarkeit prüfen

Central Nervous System Penetration of Antiretroviral Drugs: Pharmacokinetic, Pharmacodynamic and Pharmacogenomic Considerations

Clinical pharmacokinetics, 2015-06, Vol.54 (6), p.581-598

2015

Link zum Volltext

Verfügbarkeit prüfen

Clofazimine for the treatment of tuberculosis

Frontiers in pharmacology, 2023-02, Vol.14, p.1100488-1100488

2023

Link zum Volltext

Verfügbarkeit prüfen

Performance of serum C-reactive protein as a screening test for smear-negative tuberculosis in an ambulatory high HIV prevalence population

PloS one, 2011-01, Vol.6 (1), p.e15248-e15248

2011

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic accuracy of the Xpert MTB/Rif Ultra for tuberculosis adenitis

BMC infectious diseases, 2020-01, Vol.20 (1), p.33-33, Article 33

2020

Link zum Volltext

Verfügbarkeit prüfen

Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies

PLoS medicine, 2011-01, Vol.8 (1), p.e1000391-e1000391

2011

Link zum Volltext

Verfügbarkeit prüfen

Adverse drug reactions in South African patients receiving bedaquiline-containing tuberculosis treatment: an evaluation of spontaneously reported cases

BMC infectious diseases, 2019-06, Vol.19 (1), p.544-544, Article 544

2019

Link zum Volltext

Verfügbarkeit prüfen

Impact of small body weight on tenofovir-associated renal dysfunction in HIV-infected patients: a retrospective cohort study of Japanese patients

PloS one, 2011-07, Vol.6 (7), p.e22661

2011

Link zum Volltext

Verfügbarkeit prüfen

Clinical, microbiologic, and immunologic determinants of mortality in hospitalized patients with HIV-associated tuberculosis: A prospective cohort study

PLoS medicine, 2019-07, Vol.16 (7), p.e1002840-e1002840

2019

Link zum Volltext

Verfügbarkeit prüfen

Dolutegravir for second-line treatment: Programmatic implications of new evidence

Southern African journal of HIV medicine, 2022-01, Vol.23 (1), p.1428-1428

2022

Link zum Volltext

Verfügbarkeit prüfen

Neuropsychiatric toxicity and cycloserine concentrations during treatment for multidrug-resistant tuberculosis

International journal of infectious diseases, 2021-04, Vol.105, p.688-694

2021

Link zum Volltext

Verfügbarkeit prüfen

Incremental yield and cost of urine Determine TB-LAM and sputum induction in seriously ill adults with HIV

International journal of infectious diseases, 2018-10, Vol.75, p.67-73

2018

Link zum Volltext

Verfügbarkeit prüfen

Interrater agreement of two adverse drug reaction causality assessment methods: A randomised comparison of the Liverpool Adverse Drug Reaction Causality Assessment Tool and the World Health Organization-Uppsala Monitoring Centre system

PloS one, 2017-02, Vol.12 (2), p.e0172830-e0172830

2017

Link zum Volltext

Verfügbarkeit prüfen

Adherence to drug-refill is a useful early warning indicator of virologic and immunologic failure among HIV patients on first-line ART in South Africa

PloS one, 2011-03, Vol.6 (3), p.e17518-e17518

2011

Link zum Volltext

Verfügbarkeit prüfen

The determinants and impact of diagnostic delay in lymphoma in a TB and HIV endemic setting

BMC cancer, 2019-04, Vol.19 (1), p.384-384, Article 384

2019

Link zum Volltext

Verfügbarkeit prüfen

C-reactive protein and procalcitonin to discriminate between tuberculosis, Pneumocystis jirovecii pneumonia, and bacterial pneumonia in HIV-infected inpatients meeting WHO criteria for seriously ill: a prospective cohort study

BMC infectious diseases, 2018-08, Vol.18 (1), p.399-399, Article 399

2018

Link zum Volltext

Verfügbarkeit prüfen

CheXaid: deep learning assistance for physician diagnosis of tuberculosis using chest x-rays in patients with HIV

NPJ digital medicine, 2020-09, Vol.3 (1), p.115-115, Article 115

2020

Link zum Volltext

Verfügbarkeit prüfen

The antipsychotic thioridazine shows promising therapeutic activity in a mouse model of multidrug-resistant tuberculosis

PloS one, 2010-09, Vol.5 (9), p.e12640

2010

Link zum Volltext

Verfügbarkeit prüfen

Neurologic Manifestations of Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome: A Case Series

Clinical infectious diseases, 2009-06, Vol.48 (11), p.e96-e107

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 460

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(447)
Mit Volltextzugriff
(415)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

HIV infection: epidemiology, pathogenesis, treatment, and prevention

‘Covering the tail’ after stopping efavirenz-based antiretroviral therapy

Systematic review of antiretroviral-associated lipodystrophy: lipoatrophy, but not central fat gain, is an antiretroviral adverse drug reaction

Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome

Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial

Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings

Safety and adherence to intermittent pre-exposure prophylaxis (PrEP) for HIV-1 in African men who have sex with men and female sex workers

Central Nervous System Penetration of Antiretroviral Drugs: Pharmacokinetic, Pharmacodynamic and Pharmacogenomic Considerations

Clofazimine for the treatment of tuberculosis

Performance of serum C-reactive protein as a screening test for smear-negative tuberculosis in an ambulatory high HIV prevalence population

Diagnostic accuracy of the Xpert MTB/Rif Ultra for tuberculosis adenitis

Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies

Adverse drug reactions in South African patients receiving bedaquiline-containing tuberculosis treatment: an evaluation of spontaneously reported cases

Impact of small body weight on tenofovir-associated renal dysfunction in HIV-infected patients: a retrospective cohort study of Japanese patients

Clinical, microbiologic, and immunologic determinants of mortality in hospitalized patients with HIV-associated tuberculosis: A prospective cohort study

Dolutegravir for second-line treatment: Programmatic implications of new evidence

Neuropsychiatric toxicity and cycloserine concentrations during treatment for multidrug-resistant tuberculosis

Incremental yield and cost of urine Determine TB-LAM and sputum induction in seriously ill adults with HIV

Interrater agreement of two adverse drug reaction causality assessment methods: A randomised comparison of the Liverpool Adverse Drug Reaction Causality Assessment Tool and the World Health Organization-Uppsala Monitoring Centre system

Adherence to drug-refill is a useful early warning indicator of virologic and immunologic failure among HIV patients on first-line ART in South Africa

The determinants and impact of diagnostic delay in lymphoma in a TB and HIV endemic setting

C-reactive protein and procalcitonin to discriminate between tuberculosis, Pneumocystis jirovecii pneumonia, and bacterial pneumonia in HIV-infected inpatients meeting WHO criteria for seriously ill: a prospective cohort study

CheXaid: deep learning assistance for physician diagnosis of tuberculosis using chest x-rays in patients with HIV

The antipsychotic thioridazine shows promising therapeutic activity in a mouse model of multidrug-resistant tuberculosis

Neurologic Manifestations of Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome: A Case Series

Suchergebnisse filtern